These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1326 related items for PubMed ID: 10649719

  • 1. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 2. Association between nitric oxide and oxidative stress in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Duranay M, Yilmaz FM, Yilmaz G, Akay H, Parpucu H, Yücel D.
    Scand J Clin Lab Invest; 2007; 67(6):654-60. PubMed ID: 17852815
    [Abstract] [Full Text] [Related]

  • 3. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Yang CW, Hwang TL, Wu CH, Lai PC, Huang JY, Yu CC, Shyr MH, Huang CC.
    Nephrol Dial Transplant; 1996 Dec; 11(12):2466-71. PubMed ID: 9017624
    [Abstract] [Full Text] [Related]

  • 4. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, Krediet RT.
    Adv Perit Dial; 1995 Dec; 11():36-40. PubMed ID: 8534733
    [Abstract] [Full Text] [Related]

  • 5. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A, Fernando RL, Varghese Z.
    Blood Purif; 2004 Dec; 22(2):216-23. PubMed ID: 15044821
    [Abstract] [Full Text] [Related]

  • 6. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R, Schneider I, Fischer K, Deuber HJ, Osten B.
    Adv Perit Dial; 2001 Dec; 17():159-62. PubMed ID: 11510267
    [Abstract] [Full Text] [Related]

  • 7. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D, Colić M, Stanković-Popović V, Radojević M, Bokonjić D.
    Med Pregl; 2007 Dec; 60 Suppl 2():53-7. PubMed ID: 18928158
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K, Schumann RR, Stöteknuel S, Böhler J, Schollmeyer P, Dobos GJ.
    Adv Perit Dial; 1997 Dec; 13():210-3. PubMed ID: 9360683
    [Abstract] [Full Text] [Related]

  • 9. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D, Nesić V, Dimitrijević Z.
    Srp Arh Celok Lek; 1999 Dec; 127(1-2):28-31. PubMed ID: 10377837
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
    Bulut C, Oztürk R, Yilmaz GR, Parpucu H, Irmak H, Kinikli S, Duranay M, Demiröz AP.
    Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
    [Abstract] [Full Text] [Related]

  • 11. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
    Coban E, Ozdogan M, Tuncer M, Bozcuk H, Ersoy F.
    J Nephrol; 2004 Apr; 17(3):427-30. PubMed ID: 15365965
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
    Davies SJ, Bryan J, Phillips L, Russell GI.
    Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
    [Abstract] [Full Text] [Related]

  • 13. Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.
    Yoshimoto K, Saima S, Nakamura Y, Nakayama M, Kubo H, Kawaguchi Y, Nishitani H, Nakamura Y, Yasui A, Yokoyama K, Kuriyama S, Shirai D, Kugiyama A, Hayano K, Fukui H, Horigome I, Amagasaki Y, Tsubakihara Y, Kamekawa T, Ando R, Tomura S, Okamoto R, Miwa S, Koyama T, Echizen H.
    Clin Nephrol; 1998 Aug; 50(2):90-3. PubMed ID: 9725779
    [Abstract] [Full Text] [Related]

  • 14. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D, Vasilijic S, Colic M, Stankovic-Popovic V, Bokonjic D.
    Adv Perit Dial; 2009 Aug; 25():50-5. PubMed ID: 19886317
    [Abstract] [Full Text] [Related]

  • 15. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M, Loetscher P, Burger JA, Knopf HP, Schollmeyer P, Dobos GJ.
    Adv Perit Dial; 1995 Aug; 11():19-23. PubMed ID: 8534702
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH, Lin CY.
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [Abstract] [Full Text] [Related]

  • 17. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H.
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [Abstract] [Full Text] [Related]

  • 18. A drug-induced turbid peritoneal dialysate in five patients treated with continuous ambulatory peritoneal dialysis.
    Yoshimoto K, Saima S, Echizen H, Nakamura Y, Ishizaki T.
    Clin Nephrol; 1993 Aug; 40(2):114-7. PubMed ID: 8222367
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ.
    Nephrol Dial Transplant; 1994 Aug; 9(2):169-74. PubMed ID: 8190331
    [Abstract] [Full Text] [Related]

  • 20. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V.
    Ren Fail; 2008 Aug; 30(2):161-7. PubMed ID: 18300115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.